NCT06074731 Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
| NCT ID | NCT06074731 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johannes Kepler University of Linz |
| Condition | Retinal Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2017-06-01 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2017-06-01 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this pilot study we want to investigate morphological features acquired by the novel image modality and gain information regarding disease pathomechanism, development and future possible influence on disease management for patients affected by those diseases.
Eligibility Criteria
Inclusion Criteria: * Age between 5 and 110 years * Ability to follow instructions during imaging procedure * Written Informed consent Exclusion Criteria: * Dementia * Inability to follow instructions during imaging procedure * Patients who do not give informed consent
Contact & Investigator
Matthias Bolz, Prof. Dr.
PRINCIPAL INVESTIGATOR
Department for Ophthalmology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
Frequently Asked Questions
Who can join the NCT06074731 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 110 Years, studying Retinal Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06074731 currently recruiting?
Yes, NCT06074731 is actively recruiting participants. Contact the research team at matthias.bolz@kepleruniklinikum.at for enrollment information.
Where is the NCT06074731 trial being conducted?
This trial is being conducted at Linz, Austria.
Who is sponsoring the NCT06074731 clinical trial?
NCT06074731 is sponsored by Johannes Kepler University of Linz. The principal investigator is Matthias Bolz, Prof. Dr. at Department for Ophthalmology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria. The trial plans to enroll 500 participants.